Update on ranolazine in the management of angina. - Wikidata - awgldk - TriplyDB

Update on ranolazine in the management of angina.

Update on ranolazine in the management of angina.

http://www.wikidata.org/entity/Q33831222

about

Drug Therapy for Stable Angina Pectoris.

P2860

Q39102158-B427B93C-D83E-4805-A4A6-A4DA3F6BB72D

P2860

Update on ranolazine in the management of angina.

http://www.wikidata.org/entity/Q33831222

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Update on ranolazine in the management of angina.

@ast

Update on ranolazine in the management of angina.

@en

type

label

Update on ranolazine in the management of angina.

@ast

Update on ranolazine in the management of angina.

@en

prefLabel

Update on ranolazine in the management of angina.

@ast

Update on ranolazine in the management of angina.

@en

P1433

Q33831222-42573AFB-A6BE-4C26-95A8-4F8B86D5D8A7

P1476

Q33831222-D029CB9A-BD75-4B07-83E2-51A030EDF609

P2093

Q33831222-4E0436E5-F96A-404E-8BE1-B7121185E207

Q33831222-99EBD08F-84D6-4BA7-8F25-DFCCA8A43A16

Q33831222-B1DADF89-6EE2-4430-9F53-D2A6CBC23D66

P275

Q33831222-4D5B4FEA-5929-4DF8-946E-78288EC536A6

P2860

Q33831222-01276D6E-4937-4BEB-A267-2BB7A5520308

Q33831222-03A81DAB-1B05-4F35-910C-67FBE2B1139E

Q33831222-0AC3DB60-01D3-4A5C-BB76-FFD0E1D02D23

Q33831222-193380CB-B1E1-4DC3-929F-ABC81DF25EA1

Q33831222-1D865656-8DF7-4193-948F-97F6BEC923BE

Q33831222-1F2EF0AD-075E-4E18-8524-91BFE48E06FE

Q33831222-22B94A83-9686-494B-AEEF-A85FF29B1E0F

Q33831222-23D40B45-2BC3-4AE4-BB5E-9D72514BDC34

Q33831222-245D02F1-242F-427E-9B20-B33C8D6AC9E1

Q33831222-252C0497-4F32-4167-8094-56529DD0F1B3

P304

Q33831222-8ADF0F8C-7B05-4178-88DF-CFA71A2C1D0A

P31

Q33831222-0D138D35-ECA2-4031-BD18-37F9A15CA0C4

Q33831222-E02521CC-D731-48EC-B6A5-68D1C2F4EC48

P356

Q33831222-8CAEAD8D-1733-4404-9D3E-CA9A7948417E

P407

Q33831222-695EA97A-06C2-4CEE-96FC-9094A34B9B08

P478

Q33831222-62950789-8E9C-4B1C-8E40-3B5EE7D89E43

P5008

Q33831222-3ED02FCB-DA80-46E4-AD12-03B2FF91C937

P577

Q33831222-A40C1586-9BA4-4E87-A947-207CA72B5448

P698

Q33831222-4057C79B-F431-4872-A056-78C37052D587

P921

Q33831222-C551BB27-B815-4B29-86AB-A738FE173A13

Q33831222-DF91961E-B245-48C1-9E16-B1498785F0A1

Q33831222-E75CAEF2-F141-4CA9-812F-6FEB67FACA99

Q33831222-F19C20C1-22F3-4962-8165-807DDFE06B3B

Q33831222-FDF43D98-8B19-4E75-A489-A3C28290FE2F

P932

Q33831222-AFBA0DA1-287B-4C51-9EF5-FD4842E8C3DC

P356

P1433

Vascular Health and Risk Management

P1476

Update on ranolazine in the management of angina.

@en

P2093

J Nicolás Codolosa

http://www.w3.org/2001/XMLSchema#string

Subroto Acharjee

http://www.w3.org/2001/XMLSchema#string

Vincent M Figueredo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

Ranolazine: a new approach to treating an old problem.

Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload.

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.

P304

353-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S40477

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25028555

http://www.w3.org/2001/XMLSchema#string

P921

heart arrhythmia

heterocyclic compound

mechanism of action

P932

4077852

http://www.w3.org/2001/XMLSchema#string